ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer.
Nelson RangelIris Lorena SánchezDuván Sebastián ValbuenaMilena Rondón-LagosPublished in: Breast cancer (Dove Medical Press) (2024)
gene in treatment response, together with prospective studies in BC patients, could contribute to confirming our data, as well as optimizing existing treatments and exploring novel approaches to improve overall cancer treatment outcomes.
Keyphrases
- copy number
- mitochondrial dna
- genome wide
- end stage renal disease
- dna methylation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- gene expression
- electronic health record
- squamous cell carcinoma
- big data
- squamous cell
- mesenchymal stem cells
- young adults
- patient reported
- childhood cancer
- breast cancer cells
- cell therapy